Overview

Virology Follow up Study in Subjects Previously Treated With Telaprevir

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Observational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time.
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated
Collaborator:
Tibotec Pharmaceutical Limited